drugset / Trial / NCT00004840
Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants
Completed
996 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Children's Hospital of Philadelphia · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Assess the efficacy and safety of antenatal administration of thyrotropin-releasing hormone to women in premature labor to improve pulmonary outcomes in preterm infants.
Timeline
- Start
- 1998-05
- Primary completion
- —
- Completion
- 1998-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PROTIRELIN | Protein / enzyme biologic | — | Intravenous |